Holen Sie sich die Stockscreener-App
29.81
7.04%
1.96
Handel nachbörslich:
29.86
0.05
+0.17%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock - Investing.com
Hims & Hers Health Unusual Options Activity - Benzinga
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Diversify Advisory Services LLC - MarketBeat
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates - MSN
Hims & Hers Health: A Stock to Trade or Own? - MSN
Hims & Hers: Ready To Outperform Further - Seeking Alpha
Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS) - Seeking Alpha
Lake Street Private Wealth LLC Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Oak Ridge Investments LLC Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Update - MarketBeat
Hims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Hims & Hers Health down 3% after BoA says Q4 revenue could be a miss - MSN
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - sharewise
Noteworthy Friday Option Activity: UNH, HIMS, IGT - Nasdaq
BofA retains Hims & Hers stock rating amid pharma challenges - MSN
Hims & Hers Health Inc (HIMS) Shares Gap Down to $26.8776 on Jan 17 - GuruFocus.com
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - The Motley Fool
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Carnegie Investment Counsel - MarketBeat
CHURCHILL MANAGEMENT Corp Purchases Shares of 18,392 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) rises 8.3% this week, taking three-year gains to 474% - Simply Wall St
Is Hims & Hers Stock in Trouble? - MSN
(HIMS) Long Term Investment Analysis - Stock Traders Daily
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years - Yahoo Finance
Hims & Hers CFO sells shares worth $283,083 By Investing.com - Investing.com Nigeria
Hims & Hers health chief commercial officer sells $174,724 in stock - Investing.com Nigeria
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $283,039.64 in Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - MSN
Hims & Hers health chief commercial officer sells $174,724 in stock By Investing.com - Investing.com South Africa
DOCS: 3 Telemedicine Stocks Making Healthcare More Accessible - StockNews.com
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint - MSN
Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE) - Seeking Alpha
What’s Behind This Telehealth Stock’s 198% Rally? - substack.com
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation - MSN
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
GAMMA Investing LLC Buys 2,152 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
A 100x stock: Hims & Hers ($HIMS) - substack.com
Hims & Hers Health (NYSE:HIMS) Stock Rating Lowered by Citigroup - Defense World
Why Hims & Hers Health Stocks Are Dropping - TipRanks
Hims & Hers Stock Is Poised for a Major Surge in 2025 - MSN
Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 - GuruFocus.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownTime to Sell? - MarketBeat
Hims & Hers Stock Is Poised For A Major Surge In 2025 - Barchart
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
6.66%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):